Search Results - "Remenyi, Gyula"

Refine Results
  1. 1

    Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia by Mezei, Gabriella, Debreceni, Ildiko Beke, Kerenyi, Adrienne, Remenyi, Gyula, Szasz, Robert, Illes, Arpad, Kappelmayer, Janos, Batar, Peter

    Published in Platelets (Edinburgh) (03-10-2019)
    “…Since the introduction of tyrosine kinase inhibitors, the overall survival of patients with chronic myeloid leukemia has markedly improved. However long term…”
    Get full text
    Journal Article
  2. 2

    A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots by Kárai, Bettina, Habók, Mira, Reményi, Gyula, Rejtő, László, Ujfalusi, Anikó, Kappelmayer, János, Hevessy, Zsuzsanna

    Published in Annals of hematology (01-06-2019)
    “…Acute promyelocytic leukemia (APL) is generally characterized by t(15;17)(q24;q21). In some cases, the classic translocation cannot be identified by…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A Hitherto Undescribed Von Hippel Lindau Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association and Familiar Characteristics, Preliminary Data by Miklos, Udvardy, Egyed, Miklos, Bodó, Imre, Remenyi, Gyula, Bereczky, Zsuzsanna, Ujfalusi, Aniko, Illes, Arpad

    Published in Blood (29-11-2018)
    “…Introduction Von Hippel Lindau disease (VHL) is a complex disorder, in which increased oxygen demand of tissues results in a complex setting of neoplastic…”
    Get full text
    Journal Article
  5. 5

    rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics by Remenyi, Gyula, Bereczky, Zsuzsanna, Gindele, Réka, Ujfalusi, Aniko, Illes, Arpad, Udvardy, Miklos

    Published in Pathology oncology research (26-11-2021)
    “…Increased red blood cell count may result from primary erythrocytosis (polycythemia vera), but it is often due to secondary causes with increased…”
    Get full text
    Journal Article
  6. 6

    Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment by Reményi, Gyula, Szász, Róbert, Debreceni, Ildikó Beke, Szarvas, Mariann, Batár, Péter, Nagy, Béla, Kappelmayer, János, Udvardy, Miklós

    Published in Platelets (Edinburgh) (01-01-2013)
    “…Essential thrombocythemia (ET) is an acquired myeloproliferative disorder with sustained increase of platelet count. This disease may be associated with…”
    Get full text
    Journal Article
  7. 7

    Drug treatment of acute myelogenous leukaemia. Current options and future perspectives by Telek, Béla, Rejtő, László, Batár, Péter, Miltényi, Zsófia, Reményi, Gyula, Simon, Zsófia, Ujj, Zsófia, Mezei, Gabriella, Szász, Róbert, Kiss, Attila, Udvardy, Miklós, Illés, Árpád

    Published in Orvosi hetilap (29-05-2016)
    “…Acute myelogenous leukemia is a heterogeneous disease. Recent molecular mutational analysis techniques have shed more light on different, genetically well…”
    Get more information
    Journal Article
  8. 8

    Role of Mitochondrial Permeability Transition Pore in Coated-Platelet Formation by Remenyi, Gyula, Szasz, Robert, Friese, Paul, Dale, George L

    “…OBJECTIVE—Coated-platelets are a subset of cells observed during costimulation of platelets with collagen and thrombin. Important characteristics of…”
    Get full text
    Journal Article
  9. 9

    Treatment of acute myeloid leukemia -- a single center experience (2007-2013) by Selmeczi, Anna, Udvardy, Miklós, Illés, Arpád, Telek, Béla, Kiss, Attila, Batár, Péter, Reményi, Gyula, Szász, Róbert, Ujj, Zsófia, Márton, Adrienn, Ujfalusi, Anikó, Hevessy, Zsuzsanna, Pinczés, László, Bedekovics, Judit, Rejtő, László

    Published in Orvosi hetilap (27-04-2014)
    “…Mortality of acute myeloid leukemia is still 60-70% in young (<60 years) adults and 90% in elderly (≥60 years) patients. The aim of the authors was to analyse…”
    Get more information
    Journal Article
  10. 10

    The Effect of Bortezomib Containing Induction On the Long Term Outcome of autologous Haemopoietic Stem Cell Transplantation in Multiple Myeloma Patients Outside Clinical Trials - a Single Center Experience by Udvardy, Miklos, Gyula, Remenyi, Kiss, Attila, Batar, Peter, Illes, Arpad, Varoczy, Laszló, Radvanyi, Gaspar, Szasz, Robert, Rejto, Laszlo

    Published in Blood (16-11-2012)
    “…Abstract 5050 We aimed to investigate the effect of bortezomib-based induction therapy for the treatment of transplant-eligible multiple myeloma (MM) patients,…”
    Get full text
    Journal Article
  11. 11

    Tetraspanin CD9 is required for microparticle release from coated-platelets by Dale, George L., Remenyi, Gyula, Friese, Paul

    Published in Platelets (Edinburgh) (01-01-2009)
    “…CD9, a member of the tetraspanin superfamily, is the third most abundant protein on the platelet surface, but its function remains unknown. In this report, we…”
    Get full text
    Journal Article
  12. 12

    A New Approach to Predict the Chance of Infectious Complications Following Autologous Hematopoietic Stem Cell Transplantation: Mannose-Binding Lectin ELISA by Radnay, Zita, Udvardy, Miklos, Kiss, Attila, Papp, Maria, Rejto, Laszlo, Harsfalvi, Jolan, Masszi, Tamas, Szasz, Robert, Batar, Peter, Remenyi, Gyula, Telek, Bela

    Published in Blood (18-11-2011)
    “…Abstract 4492 Haematopoietic stem cell transplantation associated immuncompromised state carries high risk of infectious complications. Gram-positive cocci are…”
    Get full text
    Journal Article
  13. 13

    Bortezomib+Chemotherapy Based Salvage Combinations in Refractory AML, Preliminary Results by Udvardy, Miklos, Kiss, Attila, Telek, Bela, Szasz, Robert, Batar, Peter, Remenyi, Gyula, Cakana, Andrew, Rejto, Laszlo

    Published in Blood (16-11-2008)
    “…Bortezomib (Velcade) proved to be the standard element of refractory myeloma 2nd and 3rd line treatment, while many studies are suggesting excellent results in…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Practical considerations and questions in the treatment of chronic lymphocytic leukemia by Telek, Béla, Rejto, László, Batár, Péter, Reményi, Gyula, Szász, Róbert, Kiss, Attila, Udvardy, Miklós

    Published in Orvosi hetilap (12-06-2011)
    “…Understanding the pathogenesis and refine the treatment of chronic lymphocytic leukemia have been tremendously improved in the past decade. Treatment outcome…”
    Get more information
    Journal Article
  16. 16

    Current treatment of acute myeloid leukaemia in adults by Telek, Béla, Rejto, Lászlo, Kiss, Attila, Batár, Péter, Reményi, Gyula, Szász, Róbert, Ujj, Zsófia Ágnes, Udvardy, Miklós

    Published in Orvosi hetilap (19-02-2012)
    “…Recent cytogenetical findings and novel molecular biology results of acute myeloid leukaemia have shed new lights of our understanding in the diagnosis and…”
    Get more information
    Journal Article
  17. 17

    Transformation of chronic lymphocytic leukemia to myelodysplastic syndrome: case presentation and review of the literature by Telek, Béla, Pfliegler, György, Reményi, Gyula, Méhes, Leonóra, Batár, Péter, Udvardy, Miklós

    Published in Orvosi hetilap (12-04-2009)
    “…Chronic lymphocytic leukaemia (CLL) may transform to either malignant lymphoid disorder or increase the occurrence of solid neoplasms. However myeloid…”
    Get more information
    Journal Article
  18. 18

    One hundred fifty autologous peripheral haemopoietic stem cell transplantations and their lessons by Kiss, Attila, Reményi, Gyula, Szász, Róbert, Batár, Péter, Rejto, László, Váróczy, László, Sípos, Tamás, Kovácsné Kovács, Erika, Szarvas, Marianna, Udvardy, Miklós

    Published in Orvosi hetilap (05-07-2009)
    “…Five years ago (in September, 2003), the activity of the 5th Haemopoietic Stem Cell Transplantation Centre of Hungary has begun. This centre has been…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Paroxysmal nocturnal hemoglobinuria by Reményi, Gyula, Udvardy, Miklós, Kiss, Attila, Telek, Béla

    Published in Orvosi hetilap (28-04-2002)
    “…The current knowledge of the history, clinical course, diagnosis and treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) are summarized in this article…”
    Get more information
    Journal Article